Skip to main content

Table 3 Multivariate analysis of the five-year Cox proportional hazard model of LRRFS; OS; DMFS; and PFS. The matched pair comparison of clinical characteristics between the radiosensitive group (n = 90) and radioresistant group (n = 90)

From: Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma

Items Radiosensitive group Radioresistant group P
T Stage T1(cases) 14 11 >0.05
T2(cases) 36 33
T3(cases) 28 32
T4(cases) 12 14
N Stage N0(cases) 26 23 >0.05
N1(cases) 36 39
N2(cases) 23 20
N3(cases) 5 8
TNM Stage I(cases) 14 10 >0.05
II(cases) 35 34
III(cases) 29 32
IV(cases) 12 14
WHO Classification I (cases) 12 14 >0.05
II(cases) 24 28
III(cases) 54 48
Sex Man(cases) 49 55 >0.05
Female(cases) 41 35
Age (\( \overline{x}\pm s \))(cases) 44.5 ± 14 49.0 ± 12 >0.05
Preatment Hemoglobin(g/L) (\( \overline{x}\pm s \)) 138.5 ± 13.2 135.8 ± 15.5 >0.05
Total irradiation dose of primary nasopharyngeal carcinoma (Gy) (\( \overline{x}\pm s \)) 72.5 ± 4.2 72.6 ± 3.8 >0.05
Total irradiation dose of positive neck lymph node (Gy) (\( \overline{x}\pm s \)) 62.2 ± 2.3 64.5 ± 4.2 >0.05
Preventive irradiation dose of negative neck lymph node (Gy) (\( \overline{x}\pm s \)) 54.2 ± 3.3 53.5 ± 4.3 >0.05